Table 2.
Variable | Univariate analysis |
Multivariate analysis |
||||
---|---|---|---|---|---|---|
Hazard Ratio | 95% CI | P value | Hazard Ratio | 95% CI | P value | |
All patients | ||||||
Age, year | 0.996 | 0.979–1.014 | 0.680 | |||
≤18 | ||||||
>18 | ||||||
Gender | 0.932 | 0.520–1.663 | 0.811 | |||
Male | ||||||
Female | ||||||
Tumor site | 1.008 | 0.353–2.715 | 0.422 | |||
Femur | ||||||
Tibia | ||||||
Humeral bone | ||||||
Other | ||||||
Metastasis | 7.819 | 4.068–15.030 | <0.001a | 4.893 | 2.036-13.162 | <0.001a |
Present | ||||||
Absent | ||||||
Recurrence | 1.496 | 0.822–2.720 | 0.187 | |||
Present | ||||||
Absent | ||||||
CDK9 expression | 3.411 | 1.924–6.045 | <0.001a | 3.568 | 1.512-8.417 | 0.004a |
High | ||||||
Low | ||||||
Response to pre-operative chemotherapy | 0.240 | 0.115–0.499 | 0.002a | 0.128 | 0.026-0.651 | 0.008a |
Good | ||||||
Poor |
Statistically significant.